Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.50p -2.83% 51.50p 51.00p 52.00p 53.00p 51.50p 53.00p 40,726.00 09:26:56
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -6.1 -5.1 - 62.12

Futura Medical Share Discussion Threads

Showing 14251 to 14273 of 14275 messages
Chat Pages: 571  570  569  568  567  566  565  564  563  562  561  560  Older
DateSubjectAuthorDiscuss
28/2/2017
09:28
Mike,I wish they'd played games by raising the sp!
sportbilly1976
24/2/2017
10:15
MMs playing games mtb4
mikethebike4
24/2/2017
10:01
A few stops being hit or general profit taking from the rise from 45p a week or so back?
sportbilly1976
24/2/2017
10:00
Well I got that wrong :-)
jailbird
22/2/2017
15:44
lol guys Someone just paid 57p... must be over NMS to get 56p?It looks strong at these levels now
jailbird
22/2/2017
14:07
willoicc, I suspect if RB start to notice a (marked) drop in sales as FUM reports increase then the chequebook will be out
sportbilly1976
22/2/2017
13:41
What about Durex? Are Futura going to take a load of their business?
willoicc
22/2/2017
11:45
The teething troubles that have held back commercialisation have all been solved. One RNS and everything can change. Monty has a valid point.
j777j
22/2/2017
09:18
J777J, Maybe not 'hype' as such, but whilst it showed the efficacy of MED2002 the main share price gains will be had as/when it approaches commercialisation...only then will the Company actually receive funds back for the years spent researching and developing the products. Also, it was in direct response to Monty's 159% posts
sportbilly1976
22/2/2017
09:07
j7 over the years it has often looked very good for Futura but somehow it never quite seems to happen - it should have happened with Ken James and John Clarke on board but somehow it hasn't sorry mtb4
mikethebike4
22/2/2017
07:50
Hype?Totally disagree.The co is looking to around $600,000,000 worth of condom sales in the next few yearsUpon which they will be receiving substantial recurring revenues in the form of royalties.The pain gel markets are even greaterThe erectogenic gel,could address a market worth hundreds of millions of dollars,if not more.New product development will bring new markets to fum.I see £10 to £20 share price in the next five years.Gla.
j777j
22/2/2017
07:40
monty, Can you post anything other than that? That increase was from a much lower starting point, and ultimately on a bit of hype & hot air (which the largest shareholder sold straight into if you recall). I'd rather a few rns's with some substance and a more gradual, yet sustained rise
sportbilly1976
21/2/2017
22:08
The last good rns, shareprice went up 159% in two days. Fingers crossed boys.
montyhedge
20/2/2017
16:40
This year a lot is going to happen.They had shelf life problems,now resolved. The needed to get regulatory approval for the extended shelf life.Non EU has been approved,just waiting for EU.
j777j
20/2/2017
16:30
but when j7 ? this has been promised for years ! mtb4
mikethebike4
20/2/2017
13:16
Good work Jailbird.Once the global condom roll out is underway,I am expecting a barrage of press coverage.
j777j
19/2/2017
17:34
ok, never mind:-)
jailbird
19/2/2017
16:51
jb standard answer from JB that all of us have received when previously having made similar enquiries I am afraid mtb4
mikethebike4
17/2/2017
16:13
sanbag Your last sentance - I do likewise mtb4
mikethebike4
17/2/2017
15:07
TUT, I often watch ITV 3 & 4. They've been showing adverts regularly for quite some time now (probably months if not more) and IIRC correctly Volterol even sponsor some programmes. It's all rather galling when you see the difference in the products performance as shown by FUM back in 2013. I sometimes wonder if this company will ever get any product to a major market. http://www.futuramedical.co.uk/archive/painreliefclinicalgraphs.pdf
sandbag
16/2/2017
15:51
One of the big players will snap this up. It already has addressable markets in the billions and is a disruptive medical tech co. The business model is to collect upfront fees,milestone payments and royalties.
j777j
16/2/2017
15:13
Doubt itJust promoting their own product..FUM needs to do more of that themselves
jailbird
16/2/2017
11:14
I have noticed Voltarol have been doing frequent advertising on the radio. Trying to promote there product. Is this because they know our SPR300 will leave them dead and buried.
tutthetrader
Chat Pages: 571  570  569  568  567  566  565  564  563  562  561  560  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20170228 09:58:54